Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""ticagrelor"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 3996
Tytuł:
Thrombus remodelling by reversible and irreversible P2Y 12 inhibitors.
Autorzy:
Tunströmer K; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Faxälv L; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Larsson P; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.; Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.
Lindahl TL; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.; Department of Clinical Chemistry and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Boknäs N; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.; Department of Hematology and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Pokaż więcej
Źródło:
Platelets [Platelets] 2023 Dec; Vol. 34 (1), pp. 2157805.
Typ publikacji:
Journal Article
MeSH Terms:
Acute Coronary Syndrome*/drug therapy
Platelet Aggregation Inhibitors*/therapeutic use
Purinergic P2Y Receptor Antagonists*/therapeutic use
Thrombosis*/drug therapy
Thrombosis*/metabolism
Humans ; Blood Platelets/metabolism ; Fibrinolytic Agents/therapeutic use ; Prasugrel Hydrochloride/pharmacology ; Prasugrel Hydrochloride/therapeutic use ; Receptors, Purinergic P2Y12/metabolism ; Ticagrelor/pharmacology ; Ticagrelor/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Endothelial biomarkers and platelet reactivity on ticagrelor versus clopidogrel in patients after acute coronary syndrome with and without concomitant type 2 diabetes: a preliminary observational study.
Autorzy:
Chyrchel B; Second Department of Cardiology, Institute of Cardiology, Faculty of Medicine, Jagiellonian University Medical College, 2 Jakubowskiego Street, 30-688, Cracow, Poland. .; Department of Cardiology and Cardiovascular Interventions, University Hospital, 2 Jakubowskiego Street, 30-688, Cracow, Poland. .
Kruszelnicka O; Department of Coronary Artery Disease and Heart Failure, Institute of Cardiology, Faculty of Medicine, Jagiellonian University Medical College, 80 Prądnicka Street, 31-202, Cracow, Poland.
Surdacki A; Second Department of Cardiology, Institute of Cardiology, Faculty of Medicine, Jagiellonian University Medical College, 2 Jakubowskiego Street, 30-688, Cracow, Poland.; Department of Cardiology and Cardiovascular Interventions, University Hospital, 2 Jakubowskiego Street, 30-688, Cracow, Poland.
Pokaż więcej
Źródło:
Cardiovascular diabetology [Cardiovasc Diabetol] 2022 Nov 17; Vol. 21 (1), pp. 249. Date of Electronic Publication: 2022 Nov 17.
Typ publikacji:
Observational Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Acute Coronary Syndrome*/diagnosis
Acute Coronary Syndrome*/drug therapy
Clopidogrel*/therapeutic use
Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/drug therapy
Ticagrelor*/therapeutic use
Aged ; Female ; Humans ; Male ; Middle Aged ; Biomarkers ; Platelet Aggregation Inhibitors/therapeutic use ; Stroke Volume ; Ventricular Function, Left
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparison of Ticagrelor and Clopidogrel in Elective Coronary Stenting: A Double Blind Randomized Clinical Trial.
Autorzy:
Mehdizadeh Parizi M; Professor Kojuri Cardiology Clinic, Shiraz, Iran.
Golchin Vafa R; Professor Kojuri Cardiology Clinic, Shiraz, Iran.
Ahmadi A; Professor Kojuri Cardiology Clinic, Shiraz, Iran.
Heydarzade R; Professor Kojuri Cardiology Clinic, Shiraz, Iran.
Sadeghi M; Professor Kojuri Cardiology Clinic, Shiraz, Iran.
Khademolhossseini A; Professor Kojuri Cardiology Clinic, Shiraz, Iran.
Amiri F; Professor Kojuri Cardiology Clinic, Shiraz, Iran.
Khoshnood Mansorkhani S; Professor Kojuri Cardiology Clinic, Shiraz, Iran.
Tavan A; Professor Kojuri Cardiology Clinic, Shiraz, Iran.
Hosseini N; Professor Kojuri Cardiology Clinic, Shiraz, Iran.
Montaseri M; Professor Kojuri Cardiology Clinic, Shiraz, Iran.
Hosseini SA; Professor Kojuri Cardiology Clinic, Shiraz, Iran.
Kojuri J; Professor Kojuri Cardiology Clinic, Shiraz, Iran.; Cardiology Department, Shiraz University of Medical Sciences, Shiraz, Iran.; Clinical Education Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Pokaż więcej
Źródło:
Journal of interventional cardiology [J Interv Cardiol] 2023 Dec 26; Vol. 2023, pp. 5544440. Date of Electronic Publication: 2023 Dec 26 (Print Publication: 2023).
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Percutaneous Coronary Intervention*/adverse effects
Acute Coronary Syndrome*/therapy
Humans ; Clopidogrel/adverse effects ; Ticagrelor/therapeutic use ; Ticagrelor/adverse effects ; Platelet Aggregation Inhibitors/adverse effects ; Purinergic P2Y Receptor Antagonists/adverse effects ; Hemorrhage/epidemiology ; Aspirin/therapeutic use ; Dyspnea/etiology ; Stents ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Off-Target Effects of P2Y12 Receptor Inhibitors: Focus on Early Myocardial Fibrosis Modulation.
Autorzy:
Lofrumento F; Department of Clinical and Experimental Medicine, Policlinic 'G. Martino', University of Messina, 98122 Messina, Italy.
Irrera N; Department of Clinical and Experimental Medicine, Policlinic 'G. Martino', University of Messina, 98122 Messina, Italy.
Licordari R; Department of Clinical and Experimental Medicine, Policlinic 'G. Martino', University of Messina, 98122 Messina, Italy.
Perfetti S; Department of Clinical and Experimental Medicine, Policlinic 'G. Martino', University of Messina, 98122 Messina, Italy.
Nasso E; Department of Clinical and Experimental Medicine, Policlinic 'G. Martino', University of Messina, 98122 Messina, Italy.
Liotta P; Department of Clinical and Experimental Medicine, Policlinic 'G. Martino', University of Messina, 98122 Messina, Italy.
Isgrò G; Department of Clinical and Experimental Medicine, Policlinic 'G. Martino', University of Messina, 98122 Messina, Italy.
Garcia-Ruiz V; Cardiology Department, GIOMI Hospital, 98165 Messina, Italy.
Squadrito F; Department of Clinical and Experimental Medicine, Policlinic 'G. Martino', University of Messina, 98122 Messina, Italy.
Carerj S; Department of Clinical and Experimental Medicine, Policlinic 'G. Martino', University of Messina, 98122 Messina, Italy.
Di Bella G; Department of Clinical and Experimental Medicine, Policlinic 'G. Martino', University of Messina, 98122 Messina, Italy.
Micari A; BIOMORF Department, Policlinic 'G. Martino', University of Messina, 98122 Messina, Italy.
Costa F; BIOMORF Department, Policlinic 'G. Martino', University of Messina, 98122 Messina, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Dec 16; Vol. 24 (24). Date of Electronic Publication: 2023 Dec 16.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Purinergic P2Y Receptor Antagonists*/pharmacology
Purinergic P2Y Receptor Antagonists*/therapeutic use
Myocardial Infarction*/metabolism
Humans ; Ticagrelor/pharmacology ; beta Catenin ; Adenosine ; Pericardium/metabolism ; Fibrosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Refractory drug-induced systemic small-vessel vasculitis with two varied extracutaneous manifestations: a case report and review of the literature.
Autorzy:
Jovanovic M; Department of Internal Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia. .
Sabovic M; Department of Angiology, University Medical Centre Ljubljana, Ljubljana, Slovenia.; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2023 Oct 27; Vol. 17 (1), pp. 470. Date of Electronic Publication: 2023 Oct 27.
Typ publikacji:
Review; Case Reports; Journal Article
MeSH Terms:
Hematuria*
Vasculitis*/chemically induced
Humans ; Male ; Young Adult ; Aspirin/adverse effects ; Clopidogrel ; Immunoglobulin E ; Naproxen ; Ticagrelor
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Ticagrelor plus aspirin in patients with minor ischemic stroke and transient ischemic attack: a network meta-analysis.
Autorzy:
Li M; Department of Neurology, Xi'an International Medical Center Hospital, Xitai Road, Gaoxin District, Xi'an City, 710010, Shaanxi Province, China.
Yang Q; Department of Neurology, Xi'an International Medical Center Hospital, Xitai Road, Gaoxin District, Xi'an City, 710010, Shaanxi Province, China.
Shi J; Department of Neurology, Xi'an International Medical Center Hospital, Xitai Road, Gaoxin District, Xi'an City, 710010, Shaanxi Province, China.
Zhang X; Department of Neurology, Xi'an International Medical Center Hospital, Xitai Road, Gaoxin District, Xi'an City, 710010, Shaanxi Province, China.
Lin H; Department of Neurology, Xi'an International Medical Center Hospital, Xitai Road, Gaoxin District, Xi'an City, 710010, Shaanxi Province, China. .
Ge F; Department of Neurology, Xi'an International Medical Center Hospital, Xitai Road, Gaoxin District, Xi'an City, 710010, Shaanxi Province, China. .
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2023 Aug 14; Vol. 23 (1), pp. 303. Date of Electronic Publication: 2023 Aug 14.
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Ischemic Attack, Transient*/drug therapy
Ischemic Attack, Transient*/prevention & control
Stroke*/drug therapy
Stroke*/prevention & control
Ischemic Stroke*/drug therapy
Ischemic Stroke*/prevention & control
Humans ; Aspirin/therapeutic use ; Platelet Aggregation Inhibitors/therapeutic use ; Ticagrelor/therapeutic use ; Clopidogrel/therapeutic use ; Network Meta-Analysis ; Drug Therapy, Combination ; Hemorrhage/drug therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Differential effect of clopidogrel and ticagrelor on leukocyte count in relation to patient characteristics, biomarkers and genotype: a PLATO substudy.
Autorzy:
Nelson TA; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Parker WAE; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Ghukasyan Lakic T; Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
Westerbergh J; Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
James SK; Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
Siegbahn A; Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
Becker RC; Division of Cardiovascular Health and Disease, Heart, Lung and Vascular Institute, University of Cincinnati College of Medicine, OH, USA.
Himmelmann A; AstraZeneca Research and Development, Gothenburg, Sweden.
Wallentin L; Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
Storey RF; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Pokaż więcej
Źródło:
Platelets [Platelets] 2022 Apr 03; Vol. 33 (3), pp. 425-431. Date of Electronic Publication: 2021 Jun 02.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Biomarkers/*metabolism
Clopidogrel/*therapeutic use
Leukocyte Count/*methods
Ticagrelor/*therapeutic use
Clopidogrel/pharmacology ; Double-Blind Method ; Genotype ; Humans ; Risk Factors ; Ticagrelor/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Safety and efficacy of low-dose ticagrelor in Chinese patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Autorzy:
Wang Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Liu B; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Chen L; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Wang Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Wang Z; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Zhang X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Suo M; Emergency and Critical Care Center, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Mintz GS; Cardiovascular Research Foundation, Columbia University, New York, NY, USA.
Wu X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Pokaż więcej
Źródło:
Platelets [Platelets] 2022 Feb 17; Vol. 33 (2), pp. 304-311. Date of Electronic Publication: 2021 Apr 04.
Typ publikacji:
Journal Article
MeSH Terms:
Acute Coronary Syndrome/*drug therapy
Percutaneous Coronary Intervention/*methods
Platelet Aggregation Inhibitors/*therapeutic use
Ticagrelor/*therapeutic use
China ; Cohort Studies ; Female ; Humans ; Male ; Middle Aged ; Platelet Aggregation Inhibitors/pharmacology ; Prospective Studies ; Ticagrelor/pharmacology ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Lung protective effect of Ticagrelor in endotoxemia.
Autorzy:
Mueen RM; Department of Pharmacology & Therapeutics, Faculty of Medicine, University of Kufa, Kufa, Iraq.
Al-Juaifari M; KMG Klinikum Güstrow, Clinic for Trauma Surgery, Spinal Surgery and Orthopedics, Güstrow, Germany.
Abosaooda M; College of Pharmacy, Islamic University, Najaf, Iraq.
Qassam H; Department of Pharmacology, Faculty of Medicine, University of Kufa, Iraq.
Hadi NR; Department of Pharmacology & Therapeutics, Faculty of Medicine, University of Kufa, Kufa, Iraq.
Pokaż więcej
Źródło:
Journal of medicine and life [J Med Life] 2023 Jun; Vol. 16 (6), pp. 941-947.
Typ publikacji:
Journal Article
MeSH Terms:
Endotoxemia*/drug therapy
Sepsis*
Male ; Animals ; Mice ; F2-Isoprostanes ; Ticagrelor/pharmacology ; Ticagrelor/therapeutic use ; Lung
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Prescription patterns of P2Y12 inhibitors following revascularization in the United States: 2013-2018.
Autorzy:
Kumar A; Department of Pharmacy Practice and Administrative Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, Ohio, USA.
Lutsey PL; Division of Epidemiology and Community Health, University of Minnesota, School of Public Health, Minneapolis, Minnesota, USA.
St Peter WL; Department of Pharmaceutical Care and Health Systems, University of Minnesota, College of Pharmacy, Minneapolis, Minnesota, USA.
Schommer JC; Department of Pharmaceutical Care and Health Systems, University of Minnesota, College of Pharmacy, Minneapolis, Minnesota, USA.
Van't Hof JR; Cardiovascular Division, Lillehei Heart Institute, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
Rajpurohit A; Department of Pharmaceutical Care and Health Systems, University of Minnesota, College of Pharmacy, Minneapolis, Minnesota, USA.
Farley JF; Department of Pharmaceutical Care and Health Systems, University of Minnesota, College of Pharmacy, Minneapolis, Minnesota, USA.
Pokaż więcej
Źródło:
Clinical and translational science [Clin Transl Sci] 2023 Oct; Vol. 16 (10), pp. 1886-1897. Date of Electronic Publication: 2023 Aug 03.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Coronary Artery Disease*/drug therapy
Acute Coronary Syndrome*/chemically induced
Acute Coronary Syndrome*/drug therapy
Humans ; United States/epidemiology ; Aged ; Clopidogrel/adverse effects ; Ticagrelor/adverse effects ; Platelet Aggregation Inhibitors/adverse effects ; Purinergic P2Y Receptor Antagonists/adverse effects ; Prescriptions ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Influence of early dose reduction of ticagrelor on clinical outcomes following percutaneous coronary intervention for complex lesions.
Autorzy:
Lee Y; Division of Cardiology, Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Republic of Korea.
Shin JH; Division of Cardiology, Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Republic of Korea.
Seo SM; Division of Cardiology, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Choi IJ; Division of Cardiology, Department of Internal Medicine, Incheon St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
Lee JY; Division of Cardiology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Lee JW; Division of Cardiology, Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.
Park MW; Division of Cardiology, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Daejeon, Republic of Korea.
Kang TS; Division of Cardiology, Dankook University Hospital, Dankook University College of Medicine, Cheonan, Republic of Korea.
Choi WG; Department of Internal Medicine, College of Medicine, Chungbuk National University Hospital, Chungbuk National University, Cheongju, 28644, Republic of Korea.
Jeon KH; Division of Cardiology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Lim HS; Department of Cardiology, Ajou University School of Medicine, Suwon, Republic of Korea.; Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.
Joo HJ; Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.
Rhee SJ; Department of Cardiovascular Medicine, Regional Cardiocerebrovascular Center, Wonkwang University Hospital, Iksan, Republic of Korea.
Seo JB; Division of Cardiology, Department of Internal Medicine, Boramae Medical Center, Seoul National University College of Medicine, Seoul, Republic of Korea.
Park MS; Division of Cardiology, Dongtan Sacred Heart Hospital, 7, Keunjaebong-gil, Hwaseong-si, Gyeonggi-do, 18450, Republic of Korea.
Park SH; Division of Cardiology, Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, 31, Suncheonhyang 6-gil, Dongnam-gu, Cheonan, 31151, Republic of Korea. .
Lim YH; Division of Cardiology, Department of Internal Medicine, Hanyang University College of Medicine, 222 Wangsimni-ro, Sungdong-gu, Seoul, 04763, Republic of Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Sep 19; Vol. 13 (1), pp. 15481. Date of Electronic Publication: 2023 Sep 19.
Typ publikacji:
Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Percutaneous Coronary Intervention*/adverse effects
Humans ; Ticagrelor ; Cohort Studies ; Drug Tapering ; Platelet Aggregation Inhibitors/adverse effects ; Prospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The effect of ticagrelor on coronary microvascular function after PCI in patients with ACS compared to clopidogrel: A systematic review and meta-analysis.
Autorzy:
Qiu X; Department of Cardiology, National Key Laboratory for Innovation and Transformation of Luobing Theory, The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, Qilu Hospital of Shandong University, Jinan, China.
Li X; Department of Cardiology, National Key Laboratory for Innovation and Transformation of Luobing Theory, The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, Qilu Hospital of Shandong University, Jinan, China.
Fu K; Department of Cardiology, National Key Laboratory for Innovation and Transformation of Luobing Theory, The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, Qilu Hospital of Shandong University, Jinan, China.
Chen W; Department of Cardiology, National Key Laboratory for Innovation and Transformation of Luobing Theory, The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, Qilu Hospital of Shandong University, Jinan, China.
Chen W; Department of Cardiology, National Key Laboratory for Innovation and Transformation of Luobing Theory, The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, Qilu Hospital of Shandong University, Jinan, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Aug 29; Vol. 18 (8), pp. e0289243. Date of Electronic Publication: 2023 Aug 29 (Print Publication: 2023).
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Acute Coronary Syndrome*/drug therapy
Acute Coronary Syndrome*/surgery
Percutaneous Coronary Intervention*
Humans ; Clopidogrel/therapeutic use ; Ticagrelor/therapeutic use ; Microcirculation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparison of Different Chronic Maintenance Antithrombotic Strategies in Patients with Coronary Artery Disease: A Systematic Review and Network Meta-Analysis.
Autorzy:
Zhang J; Department of Cardiology, West China Hospital of Sichuan University, Chengdu, China.
Chen Z; Department of Cardiology, West China Hospital of Sichuan University, Chengdu, China.
Cai Y; Chinese Evidence-Based Medicine Center and MAGIC-China Center, West China Hospital, Sichuan University, Chengdu, China.
Li C; Department of Cardiology, West China Hospital of Sichuan University, Chengdu, China.
He Y; Department of Cardiology, West China Hospital of Sichuan University, Chengdu, China.
Pokaż więcej
Źródło:
Cardiovascular therapeutics [Cardiovasc Ther] 2023 Aug 17; Vol. 2023, pp. 5446271. Date of Electronic Publication: 2023 Aug 17 (Print Publication: 2023).
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Coronary Artery Disease*/diagnosis
Coronary Artery Disease*/drug therapy
Ischemic Stroke*
Humans ; Network Meta-Analysis ; Rivaroxaban ; Clopidogrel ; Fibrinolytic Agents/adverse effects ; Platelet Aggregation Inhibitors/adverse effects ; Ticagrelor ; Aspirin/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy and safety of abciximab versus tirofiban in addition to ticagrelor in STEMI patients undergoing primary percutaneous intervention.
Autorzy:
Revilla-Martí P; Cardiology Department, Hospital Clínico Universitario 'Lozano Blesa', Zaragoza, Spain.
Linares-Vicente JA; Cardiology Department, Hospital Clínico Universitario 'Lozano Blesa', Zaragoza, Spain.
Martínez Labuena A; Cardiology Department, Hospital Clínico Universitario 'Lozano Blesa', Zaragoza, Spain.
Jiménez Melo O; Cardiology Department, Hospital Clínico Universitario 'Lozano Blesa', Zaragoza, Spain.
Morlanes Gracia P; Cardiology Department, Hospital Clínico Universitario 'Lozano Blesa', Zaragoza, Spain.
Meseguer González D; Cardiology Department, Hospital Clínico Universitario 'Lozano Blesa', Zaragoza, Spain.
Lukic A; Cardiology Department, Hospital Clínico Universitario 'Lozano Blesa', Zaragoza, Spain.
Simó Sánchez B; Cardiology Department, Hospital Clínico Universitario 'Lozano Blesa', Zaragoza, Spain.
Ruiz Arroyo JR; Cardiology Department, Hospital Clínico Universitario 'Lozano Blesa', Zaragoza, Spain.
Pokaż więcej
Źródło:
Platelets [Platelets] 2022 Feb 17; Vol. 33 (2), pp. 265-272. Date of Electronic Publication: 2021 Feb 09.
Typ publikacji:
Journal Article
MeSH Terms:
Abciximab/*therapeutic use
Percutaneous Coronary Intervention/*methods
Platelet Aggregation Inhibitors/*therapeutic use
ST Elevation Myocardial Infarction/*drug therapy
Ticagrelor/*therapeutic use
Tirofiban/*therapeutic use
Abciximab/pharmacology ; Female ; Humans ; Male ; Middle Aged ; Platelet Aggregation Inhibitors/pharmacology ; ST Elevation Myocardial Infarction/pathology ; Ticagrelor/pharmacology ; Tirofiban/pharmacology ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Recovery of platelet reactivity following cessation of either aspirin or ticagrelor in patients treated with dual antiplatelet therapy following percutaneous coronary intervention: a GLOBAL LEADERS substudy.
Autorzy:
Hennigan BW; Department of Cardiology, Golden Jubilee National Hospital, Glasgow, UK.
Good R; Department of Cardiology, Golden Jubilee National Hospital, Glasgow, UK.
Adamson C; Department of Cardiology, Golden Jubilee National Hospital, Glasgow, UK.
Parker WAE; Cardiovascular Research Unit, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Martin L; Department of Cardiology, Golden Jubilee National Hospital, Glasgow, UK.
Anderson L; Department of Cardiology, Golden Jubilee National Hospital, Glasgow, UK.
Campbell M; Department of Cardiology, Golden Jubilee National Hospital, Glasgow, UK.
Serruys PW; Department of Cardiology, National University of Ireland, University Road, Galway, Ireland.; National Heart and Lung Institute, Imperial College London, London, UK.
Storey RF; Cardiovascular Research Unit, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Oldroyd KG; Department of Cardiology, Golden Jubilee National Hospital, Glasgow, UK.
Pokaż więcej
Źródło:
Platelets [Platelets] 2022 Jan 02; Vol. 33 (1), pp. 141-146. Date of Electronic Publication: 2020 Dec 26.
Typ publikacji:
Journal Article
MeSH Terms:
Aspirin/*therapeutic use
Blood Platelets/*drug effects
Dual Anti-Platelet Therapy/*methods
Percutaneous Coronary Intervention/*methods
Platelet Aggregation Inhibitors/*therapeutic use
Ticagrelor/*therapeutic use
Aspirin/pharmacology ; Humans ; Platelet Aggregation Inhibitors/pharmacology ; Ticagrelor/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Population pharmacokinetic-pharmacodynamic modeling of PB2452, a monoclonal antibody fragment being developed as a ticagrelor reversal agent, in healthy volunteers.
Autorzy:
Kathman SJ; PPD, Wilmington, North Carolina, USA.
Wheeler JJ; PPD, Wilmington, North Carolina, USA.
Bhatt DL; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Arnold SE; PhaseBio Pharmaceuticals, Inc., Malvern, Pennsylvania, USA.
Lee JS; PhaseBio Pharmaceuticals, Inc., Malvern, Pennsylvania, USA.
Pokaż więcej
Źródło:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2022 Jan; Vol. 11 (1), pp. 68-81. Date of Electronic Publication: 2021 Nov 09.
Typ publikacji:
Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial
MeSH Terms:
Anticoagulation Reversal/*methods
Broadly Neutralizing Antibodies/*administration & dosage
Immunoglobulin Fragments/*administration & dosage
Immunoglobulin Fragments/*pharmacology
Ticagrelor/*antagonists & inhibitors
Adolescent ; Adult ; Bayes Theorem ; Blood Platelets/drug effects ; Broadly Neutralizing Antibodies/pharmacology ; Broadly Neutralizing Antibodies/therapeutic use ; Dose-Response Relationship, Drug ; Double-Blind Method ; Female ; Healthy Volunteers ; Humans ; Immunoglobulin Fragments/therapeutic use ; Male ; Middle Aged ; Models, Biological ; Platelet Aggregation Inhibitors/pharmacology ; Ticagrelor/administration & dosage ; Ticagrelor/pharmacokinetics ; Ticagrelor/pharmacology ; Ticagrelor/therapeutic use ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effects of Antiplatelet Drugs on Platelet-Dependent Coagulation Reactions.
Autorzy:
Muravlev IA; Chazov National Medical Research Center of Cardiology, Russian Ministry of Health, Academician Chazov Str., 15a, Moscow 121552, Russia.
Dobrovolsky AB; Chazov National Medical Research Center of Cardiology, Russian Ministry of Health, Academician Chazov Str., 15a, Moscow 121552, Russia.
Antonova OA; Chazov National Medical Research Center of Cardiology, Russian Ministry of Health, Academician Chazov Str., 15a, Moscow 121552, Russia.
Khaspekova SG; Chazov National Medical Research Center of Cardiology, Russian Ministry of Health, Academician Chazov Str., 15a, Moscow 121552, Russia.
Alieva AK; Chazov National Medical Research Center of Cardiology, Russian Ministry of Health, Academician Chazov Str., 15a, Moscow 121552, Russia.
Pevzner DV; Chazov National Medical Research Center of Cardiology, Russian Ministry of Health, Academician Chazov Str., 15a, Moscow 121552, Russia.
Mazurov AV; Chazov National Medical Research Center of Cardiology, Russian Ministry of Health, Academician Chazov Str., 15a, Moscow 121552, Russia.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2023 Jul 14; Vol. 13 (7). Date of Electronic Publication: 2023 Jul 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Platelet Aggregation Inhibitors*/pharmacology
Blood Platelets*
Humans ; Ticagrelor/pharmacology ; Thrombin/pharmacology ; Alprostadil/pharmacology ; Blood Coagulation ; Aspirin/pharmacology ; Fibrin/pharmacology ; Collagen/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pathophysiological and Molecular Basis of the Side Effects of Ticagrelor: Lessons from a Case Report.
Autorzy:
Cesarini D; S.O.D. Cardiologia Interventistica d'Urgenza, AOU Careggi, 50134 Florence, Italy.
Muraca I; S.O.D. Cardiologia Interventistica d'Urgenza, AOU Careggi, 50134 Florence, Italy.
Berteotti M; Atherothrombotic Center, Department of Experimental and Clinical Medicine, University of Florence, AOU Careggi, 50134 Florence, Italy.
Gori AM; Atherothrombotic Center, Department of Experimental and Clinical Medicine, University of Florence, AOU Careggi, 50134 Florence, Italy.
Sorrentino A; Atherothrombotic Center, Department of Experimental and Clinical Medicine, University of Florence, AOU Careggi, 50134 Florence, Italy.
Bertelli A; Atherothrombotic Center, Department of Experimental and Clinical Medicine, University of Florence, AOU Careggi, 50134 Florence, Italy.
Marcucci R; Atherothrombotic Center, Department of Experimental and Clinical Medicine, University of Florence, AOU Careggi, 50134 Florence, Italy.
Valenti R; S.O.D. Cardiologia Interventistica d'Urgenza, AOU Careggi, 50134 Florence, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jun 29; Vol. 24 (13). Date of Electronic Publication: 2023 Jun 29.
Typ publikacji:
Case Reports
MeSH Terms:
Percutaneous Coronary Intervention*/adverse effects
Myocardial Infarction*/therapy
Humans ; Ticagrelor/adverse effects ; Platelet Aggregation Inhibitors/adverse effects ; Aspirin/therapeutic use ; Treatment Outcome
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 3996

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies